Loading...
COVID Moonshot: Open Science Discovery of SARS-CoV-2 Main Protease Inhibitors by Combining Crowdsourcing, High-Throughput Experiments, Computational Simulations, and Machine Learning
The COVID Moonshot Consortium
The COVID Moonshot Consortium
Citations
Altmetric:
Genre
Pre-print
Date
2020-10-30
Advisor
Committee member
Group
Department
Chemistry
Subject
Permanent link to this record
Collections
Research Projects
Organizational Units
Journal Issue
DOI
https://doi.org/10.1101/2020.10.29.339317
Abstract
Herein we provide a living summary of the data generated during the COVID Moonshot project
focused on the development of SARS-CoV-2 main protease (Mpro) inhibitors. Our approach uniquely combines crowdsourced medicinal chemistry insights with high throughput crystallography, exascale computational chemistry infrastructure for simulations, and machine learning in triaging designs and predicting
synthetic routes. This manuscript describes our methodologies leading to both covalent and non-covalent
inhibitors displaying protease IC50 values under 150 nM and viral inhibition under 5 uM in multiple different
viral replication assays. Furthermore, we provide over 200 crystal structures of fragment-like and lead-like
molecules in complex with the main protease. Over 1000 synthesized and ordered compounds are also
reported with the corresponding activity in Mpro enzymatic assays using two different experimental setups. The data referenced in this document will be continually updated to reflect the current experimental
progress of the COVID Moonshot project, and serves as a citable reference for ensuing publications. All of
the generated data is open to other researchers who may find it of use.
Description
Citation
The COVID Moonshot Consortium. COVID Moonshot: Open Science Discovery of SARS-CoV-2 Main Protease Inhibitors by Combining Crowdsourcing, High-Throughput Experiments, Computational Simulations, and Machine Learning. bioRxiv 2020.10.29.339317; doi: https://doi.org/10.1101/2020.10.29.339317
Citation to related work
bioRxiv
Has part
ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu